EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Exploring the impact of pharmacogenetics on personalized medicine: A systematic review

Laura Amaro-Álvarez, Jaime Cordero-Ramos, Miguel Ángel Calleja-Hernández

Farmacia Hospitalaria · 2024-11 · 48 (6) · 299-309

DOI: 10.1016/j.farma.2023.12.004 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Farmacia Hospitalaria, 2024-11. Verfasst von Laura Amaro-Álvarez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Servicio Farmacia hospitalaria, Hospital Virgen Macarena, Sevilla, Spain. Hauptthemen laut MEDLINE: Precision Medicine, Pharmacogenetics. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Pharmacogenetics evaluates how genetic variations influence drug responses. Nowadays, genetic tests have advanced, becoming more affordable, and its integration is supported by stronger clinical evidence. Guidelines such as those from CPIC (Clinical Pharmacogenetics Implementation Consortium) and resources like PharmGKB facilitate genotype-based prescribing; and organizations like the FDA promote genetic testing before initiating certain medications. Preventive pharmacogenetic panels seem promising, but further research on biomarkers and diverse populations is needed. The aim of this review is to analyze recent evidence on the genotype-drug response relationship to examine how the genetic profile of patients influences the clinical response to treatments, and analyze the areas of research that need further study to advance towards a genetic-based precision medicine. MATERIALS AND METHODS: A systematic search was conducted on PubMed to identify articles investigating the genotype-drug response relationship. The search strategy included terms such as "pharmacogenetics", "personalized treatment", "precision medicine", "dose adjustment", "individualizing dosing", "clinical routine", and "clinical practice." Clinical trials, observational studies, and meta-analyses published in English or Spanish between 2013 and 2023 were included. The initial search resulted in a total of 136 articles for analysis. RESULTS: 49 articles were included for the final analysis following review by 2 investigators. A relationship between genetic polymorphisms and drug response or toxicity was found for drugs such as opioids, GLP-1 agonists, tacrolimus, oral anticoagulants, antineoplastics, atypical antipsychotics, efavirenz, clopidogrel, lamotrigine, anti-TNFα agents, voriconazole, antidepressants, or statins. However, for drugs like metformin, quetiapine, irinotecan, bisoprolol, and anti-VEGF agents, no statistically significant association between genotype and response was found. CONCLUSION: The studies analyzed in this review suggest a strong correlation between genetic variability and individual drug responses, supporting the use of pharmacogenetics for treatment optimization. However, for certain drugs like metformin or quetiapine, the influence of genotype on their response remains unclear. More studies with larger sample sizes, greater ethnic diversity, and consideration of non-genetic factors are needed. The lack of standardization in analysis methods and accessibility to genetic testing are significant challenges in this field. As a conclusion, pharmacogenetics shows immense potential in personalized medicine, but further research is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicinePharmacogeneticsHumansGenotype

Stichwörter der Autor:innen

Adverse drug reactionsBiomarcadoresBiomarkersClinical implementationFarmacogenéticaGeneticGenetic testsGenotipoGenotypeGenéticaImplementación clínicaMedicina de precisiónMedicina personalizadaPersonalized medicinePharmacogenetics

Autor:innen und Institutionen

  • Servicio Farmacia hospitalaria, Hospital Virgen Macarena, Sevilla, Spain.
  • Servicio Farmacia hospitalaria, Hospital Virgen Macarena, Sevilla, Spain. Electronic address: corderojaime7@gmail.com.

Zitieren

APA

Amaro-Álvarez, L., Cordero-Ramos, J., & Calleja-Hernández, M. Á. (2024). Exploring the impact of pharmacogenetics on personalized medicine: A systematic review. Farmacia Hospitalaria, 48(6), 299-309. https://doi.org/10.1016/j.farma.2023.12.004

Vancouver

Amaro-Álvarez L, Cordero-Ramos J, Calleja-Hernández MÁ. Exploring the impact of pharmacogenetics on personalized medicine: A systematic review. Farmacia Hospitalaria. 2024;48(6):299-309. doi:10.1016/j.farma.2023.12.004

BibTeX
@article{Amarolvarez2024,
  author = {Amaro-Álvarez, Laura and Cordero-Ramos, Jaime and Calleja-Hernández, Miguel Ángel},
  title = {Exploring the impact of pharmacogenetics on personalized medicine: A systematic review},
  journal = {Farmacia Hospitalaria},
  year = {2024},
  volume = {48},
  number = {6},
  pages = {299--309},
  doi = {10.1016/j.farma.2023.12.004}
}
Kostenlos starten →